Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Factor Health MD vs Layla

Factor Health MD
Graded #164

Lower grade

vs+3.4000000000000057
Layla
Graded #101

Higher grade

The verdict

Layla takes it — 70.9/100 to 67.5/100.

Layla grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Layla is a US telehealth weight-loss program built around semaglutide, offering compounded semaglutide as injections and as oral dropper drops, plus compounded tirzepatide and a brand-inclusive GLP-1…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueFactor Health MD +18
84
66
Dose & formulationLayla +27
69
96
Clinical oversightLayla +7
69
76
Labs & monitoringLayla +1
51
52
FulfillmentLayla +8
57
65
Contract termsEven
55
55
Factor Health MD · left barLayla · right bar

The numbers

MetricFactor Health MDLayla
WeighScore67.5/10070.9/100
GradeCC
Scorecard rank#164#101
Semaglutide$99/mo (starting dose, compounded)$237/mo (all doses, compounded)
Tirzepatide$149/mo (compounded)$199/mo (all doses, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Factor Health MD

Graded #164 · C

Strengths

  • Three-GLP-1 lineup including liraglutide — rare in DTC and useful for patients sensitive to newer molecules
  • Aggressive $99/mo starting tier with all doses included
  • Multi-product platform (GLP-1, longevity, vitamin injectables, men's health, bundles)
  • HSA/FSA accepted — uncommon for compounded GLP-1
  • St. Petersburg, FL location and phone (305-930-8817) for accountability

Where it loses points

  • 503A/503B pharmacy partner not named
  • Full states-served list not disclosed
  • No named medical director
  • FDA compounded-medication disclaimer not prominently displayed
  • Corporate legal entity not disclosed
Layla

Graded #101 · C

Strengths

  • Oral semaglutide dropper option plus injectable semaglutide and tirzepatide, with a brand-name upgrade path
  • Named Medical Director (Dr. Ruth Cohen) and 24-7 doctor messaging
  • Quiz-based intake with fast three to five day shipping

Where it loses points

  • Brand-inclusive GLP-1 program is expensive, starting around 1,299 dollars
  • States served are not published on the site
  • Support phone line uses a UK format, and the compounding pharmacy is not named

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard